We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Online Tool Helps Validate Clinical Molecular Assays

By LabMedica International staff writers
Posted on 08 Dec 2010
A new online tool helps clinical laboratories standardize their verification and validation requirements and eases adoption of new molecular tests.

The web-based program is designed to assist laboratories in identifying molecular assay verification or validation requirements to comply with clinical laboratory improvement amendments (CLIA) accreditation requirements in the United States and meet International Standards Organization (ISO) standards in Europe. More...
Compliance with CLIA requirements is necessary for any laboratory that reports patient results for clinical purposes in the United States.

The EZValidation Online Tool, which was launched by Life Technologies' (Carlsbad, CA, USA) and configured to work with the company's AcroMetrix quality control materials, helps labs establish an easy-to-use workflow from protocol development through the final report generation. The tool provides a simplified path for adopting new molecular assays through ISO 15189, CLIA, College of American Pathologists (CAP) and New York State guidelines. The online tool is also updateable for new guidelines and tests as they are developed.

Kimberlee Caple, head of Molecular Medicine Products at Life Technologies said, "EZValidation's Online Tool will help clinical labs maintain their compliance and adopt new molecular tests to foster the accuracy, reliability, and timeliness of patients' results." She added, "The clinical laboratory market is the front line for the adoption of molecular medicine in healthcare, and EZValidation helps those facilities incorporate molecular assays more efficiently, accurately and effectively."

Related Links:
Life Technologies



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.